{"id":"https://openalex.org/W2100705331","doi":"https://doi.org/10.4049/jimmunol.175.10.6531","title":"Prostaglandin D2 Causes Preferential Induction of Proinflammatory Th2 Cytokine Production through an Action on Chemoattractant Receptor-Like Molecule Expressed on Th2 Cells","display_name":"Prostaglandin D2 Causes Preferential Induction of Proinflammatory Th2 Cytokine Production through an Action on Chemoattractant Receptor-Like Molecule Expressed on Th2 Cells","alternate_titles":[],"publication_year":2005,"publication_date":"2005-11-01","ids":{"openalex":"https://openalex.org/W2100705331","doi":"https://doi.org/10.4049/jimmunol.175.10.6531","mag":"2100705331","pmid":"https://pubmed.ncbi.nlm.nih.gov/16272307"},"language":"en","primary_location":{"id":"doi:10.4049/jimmunol.175.10.6531","doi":"https://doi.org/10.4049/jimmunol.175.10.6531","is_oa":false,"landing_page_url":"https://doi.org/10.4049/jimmunol.175.10.6531","pdf_url":null,"source":{"id":"https://openalex.org/S38008053","display_name":"The Journal of Immunology","issn_l":"0022-1767","issn":["0022-1767","1550-6606"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4320800377","host_organization_name":"American Association of Immunologists","host_organization_lineage":["https://openalex.org/P4320800377"],"host_organization_lineage_names":["American Association of Immunologists"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Immunology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2100705331"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5064578769","display_name":"Luzheng Xue","orcid":"https://orcid.org/0000-0003-0042-1262","observed_orcids":["https://orcid.org/0000-0003-0042-1262"]},"institutions":[{"id":"https://openalex.org/I4210106026","display_name":"Oxagen (United Kingdom)","ror":"https://ror.org/01eag6b04","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210106026"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Luzheng Xue","raw_affiliation_strings":["Oxagen Limited , Abingdon, Oxon ,","Oxagen Limited, Abingdon, Oxon, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oxagen Limited , Abingdon, Oxon ,","institution_ids":["https://openalex.org/I4210106026"]},{"raw_affiliation_string":"Oxagen Limited, Abingdon, Oxon, United Kingdom","institution_ids":["https://openalex.org/I4210106026"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110006112","display_name":"Sh\u00e2n L. Gyles","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210106026","display_name":"Oxagen (United Kingdom)","ror":"https://ror.org/01eag6b04","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210106026"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Sha\u0302n L Gyles","raw_affiliation_strings":["Oxagen Limited , Abingdon, Oxon ,","Oxagen Limited, Abingdon, Oxon, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oxagen Limited , Abingdon, Oxon ,","institution_ids":["https://openalex.org/I4210106026"]},{"raw_affiliation_string":"Oxagen Limited, Abingdon, Oxon, United Kingdom","institution_ids":["https://openalex.org/I4210106026"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042722747","display_name":"Frank R. Wettey","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210106026","display_name":"Oxagen (United Kingdom)","ror":"https://ror.org/01eag6b04","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210106026"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Frank R Wettey","raw_affiliation_strings":["Oxagen Limited , Abingdon, Oxon ,","Oxagen Limited, Abingdon, Oxon, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oxagen Limited , Abingdon, Oxon ,","institution_ids":["https://openalex.org/I4210106026"]},{"raw_affiliation_string":"Oxagen Limited, Abingdon, Oxon, United Kingdom","institution_ids":["https://openalex.org/I4210106026"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018406596","display_name":"Lucien Gazi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210106026","display_name":"Oxagen (United Kingdom)","ror":"https://ror.org/01eag6b04","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210106026"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Lucien Gazi","raw_affiliation_strings":["Oxagen Limited , Abingdon, Oxon ,","Oxagen Limited, Abingdon, Oxon, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oxagen Limited , Abingdon, Oxon ,","institution_ids":["https://openalex.org/I4210106026"]},{"raw_affiliation_string":"Oxagen Limited, Abingdon, Oxon, United Kingdom","institution_ids":["https://openalex.org/I4210106026"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081574457","display_name":"Elizabeth R. Townsend","orcid":"https://orcid.org/0009-0005-0617-214X","observed_orcids":["https://orcid.org/0009-0005-0617-214X"]},"institutions":[{"id":"https://openalex.org/I4210106026","display_name":"Oxagen (United Kingdom)","ror":"https://ror.org/01eag6b04","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210106026"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Elizabeth Townsend","raw_affiliation_strings":["Oxagen Limited , Abingdon, Oxon ,","Oxagen Limited, Abingdon, Oxon, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oxagen Limited , Abingdon, Oxon ,","institution_ids":["https://openalex.org/I4210106026"]},{"raw_affiliation_string":"Oxagen Limited, Abingdon, Oxon, United Kingdom","institution_ids":["https://openalex.org/I4210106026"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028196368","display_name":"Michael Hunter","orcid":"https://orcid.org/0000-0002-0895-9633","observed_orcids":["https://orcid.org/0000-0002-0895-9633"]},"institutions":[{"id":"https://openalex.org/I4210106026","display_name":"Oxagen (United Kingdom)","ror":"https://ror.org/01eag6b04","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210106026"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Michael G Hunter","raw_affiliation_strings":["Oxagen Limited , Abingdon, Oxon ,","Oxagen Limited, Abingdon, Oxon, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oxagen Limited , Abingdon, Oxon ,","institution_ids":["https://openalex.org/I4210106026"]},{"raw_affiliation_string":"Oxagen Limited, Abingdon, Oxon, United Kingdom","institution_ids":["https://openalex.org/I4210106026"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5078390502","display_name":"Roy Pettipher","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210106026","display_name":"Oxagen (United Kingdom)","ror":"https://ror.org/01eag6b04","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210106026"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Roy Pettipher","raw_affiliation_strings":["Oxagen Limited , Abingdon, Oxon ,","Oxagen Limited, Abingdon, Oxon, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oxagen Limited , Abingdon, Oxon ,","institution_ids":["https://openalex.org/I4210106026"]},{"raw_affiliation_string":"Oxagen Limited, Abingdon, Oxon, United Kingdom","institution_ids":["https://openalex.org/I4210106026"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210106026"],"apc_list":{"value":3500,"currency":"USD","value_usd":3500},"apc_paid":null,"fwci":5.7975,"has_fulltext":false,"cited_by_count":292,"citation_normalized_percentile":{"value":0.9603206,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":95,"max":100},"biblio":{"volume":"175","issue":"10","first_page":"6531","last_page":"6536"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10051","display_name":"Asthma and respiratory diseases","score":0.8496000170707703,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10051","display_name":"Asthma and respiratory diseases","score":0.8496000170707703,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":0.08079999685287476,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11346","display_name":"Mast cells and histamine","score":0.030899999663233757,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/prostaglandin-d2","display_name":"prostaglandin D2","score":1.0},{"id":"https://openalex.org/keywords/crth2","display_name":"CRTH2","score":0.9570000171661377},{"id":"https://openalex.org/keywords/th2-cells","display_name":"Th2 cells","score":0.8360000252723694},{"id":"https://openalex.org/keywords/allergic-inflammation","display_name":"allergic inflammation","score":0.8659999966621399},{"id":"https://openalex.org/keywords/il-4","display_name":"IL-4","score":0.8410000205039978},{"id":"https://openalex.org/keywords/il-5","display_name":"IL-5","score":0.9980000257492065},{"id":"https://openalex.org/keywords/il-13","display_name":"IL-13","score":1.0},{"id":"https://openalex.org/keywords/il-10","display_name":"IL-10","score":0.7789999842643738},{"id":"https://openalex.org/keywords/crth2-antagonist","display_name":"CRTH2 antagonist","score":0.7319999933242798},{"id":"https://openalex.org/keywords/ramatroban","display_name":"ramatroban","score":0.9549999833106995},{"id":"https://openalex.org/keywords/mast-cells","display_name":"mast cells","score":0.5720000267028809}],"concepts":[{"id":"https://openalex.org/C2777361909","wikidata":"https://www.wikidata.org/wiki/Q419750","display_name":"Prostaglandin D2","level":3,"score":0.8081369996070862},{"id":"https://openalex.org/C2778690821","wikidata":"https://www.wikidata.org/wiki/Q212354","display_name":"Cytokine","level":2,"score":0.6730090975761414},{"id":"https://openalex.org/C2779675166","wikidata":"https://www.wikidata.org/wiki/Q4732119","display_name":"Allergic inflammation","level":3,"score":0.6359182596206665},{"id":"https://openalex.org/C2778266237","wikidata":"https://www.wikidata.org/wiki/Q962217","display_name":"Prostanoid","level":3,"score":0.5800502896308899},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.5434203147888184},{"id":"https://openalex.org/C164027704","wikidata":"https://www.wikidata.org/wiki/Q3491837","display_name":"Proinflammatory cytokine","level":3,"score":0.5231488943099976},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.445348858833313},{"id":"https://openalex.org/C2778122271","wikidata":"https://www.wikidata.org/wiki/Q410943","display_name":"Receptor antagonist","level":4,"score":0.4302878677845001},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.4246000051498413},{"id":"https://openalex.org/C2778070265","wikidata":"https://www.wikidata.org/wiki/Q18048067","display_name":"Thymic stromal lymphopoietin","level":3,"score":0.42221519351005554},{"id":"https://openalex.org/C2776914184","wikidata":"https://www.wikidata.org/wiki/Q101991","display_name":"Inflammation","level":2,"score":0.3951754570007324},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.38965699076652527},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3682093322277069},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.11717182397842407},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.11441722512245178}],"mesh":[{"descriptor_ui":"D001483","descriptor_name":"Base Sequence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002227","descriptor_name":"Carbazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D002478","descriptor_name":"Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004247","descriptor_name":"DNA","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D005231","descriptor_name":"Fatty Acids, Unsaturated","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006827","descriptor_name":"Hydantoins","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D006834","descriptor_name":"Hydrazines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D007249","descriptor_name":"Inflammation","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D007249","descriptor_name":"Inflammation","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D011971","descriptor_name":"Receptors, Immunologic","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D011971","descriptor_name":"Receptors, Immunologic","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D011971","descriptor_name":"Receptors, Immunologic","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D011971","descriptor_name":"Receptors, Immunologic","qualifier_ui":"Q000819","qualifier_name":"agonists","is_major_topic":false},{"descriptor_ui":"D011982","descriptor_name":"Receptors, Prostaglandin","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D011982","descriptor_name":"Receptors, Prostaglandin","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D011982","descriptor_name":"Receptors, Prostaglandin","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D011982","descriptor_name":"Receptors, Prostaglandin","qualifier_ui":"Q000819","qualifier_name":"agonists","is_major_topic":false},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D015230","descriptor_name":"Prostaglandin D2","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D015230","descriptor_name":"Prostaglandin D2","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D015847","descriptor_name":"Interleukin-4","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":false},{"descriptor_ui":"D015847","descriptor_name":"Interleukin-4","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D015848","descriptor_name":"Interleukin-5","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":false},{"descriptor_ui":"D015848","descriptor_name":"Interleukin-5","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D015854","descriptor_name":"Up-Regulation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D016207","descriptor_name":"Cytokines","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":true},{"descriptor_ui":"D018418","descriptor_name":"Th2 Cells","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D018418","descriptor_name":"Th2 Cells","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D018418","descriptor_name":"Th2 Cells","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D018793","descriptor_name":"Interleukin-13","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":false},{"descriptor_ui":"D018793","descriptor_name":"Interleukin-13","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D018836","descriptor_name":"Inflammation Mediators","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D019086","descriptor_name":"Bridged Bicyclo Compounds, Heterocyclic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.4049/jimmunol.175.10.6531","doi":"https://doi.org/10.4049/jimmunol.175.10.6531","is_oa":false,"landing_page_url":"https://doi.org/10.4049/jimmunol.175.10.6531","pdf_url":null,"source":{"id":"https://openalex.org/S38008053","display_name":"The Journal of Immunology","issn_l":"0022-1767","issn":["0022-1767","1550-6606"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4320800377","host_organization_name":"American Association of Immunologists","host_organization_lineage":["https://openalex.org/P4320800377"],"host_organization_lineage_names":["American Association of Immunologists"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Immunology","raw_type":"journal-article"},{"id":"pmid:16272307","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16272307","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of immunology (Baltimore, Md. : 1950)","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":39,"referenced_works":["https://openalex.org/W163460441","https://openalex.org/W1487331723","https://openalex.org/W1515615230","https://openalex.org/W1519407136","https://openalex.org/W1565847282","https://openalex.org/W1603889483","https://openalex.org/W1680932833","https://openalex.org/W1768025161","https://openalex.org/W1838821626","https://openalex.org/W1928811075","https://openalex.org/W1971595233","https://openalex.org/W1977647049","https://openalex.org/W1993946895","https://openalex.org/W1994362051","https://openalex.org/W1999238148","https://openalex.org/W2020191064","https://openalex.org/W2057530935","https://openalex.org/W2064590804","https://openalex.org/W2066882388","https://openalex.org/W2073939652","https://openalex.org/W2081657416","https://openalex.org/W2083616068","https://openalex.org/W2089709635","https://openalex.org/W2099865106","https://openalex.org/W2103069823","https://openalex.org/W2115200110","https://openalex.org/W2136651927","https://openalex.org/W2142492100","https://openalex.org/W2150068375","https://openalex.org/W2151627258","https://openalex.org/W2161074777","https://openalex.org/W2163870925","https://openalex.org/W2165201838","https://openalex.org/W2166893697","https://openalex.org/W2167704621","https://openalex.org/W2191654227","https://openalex.org/W2315018741","https://openalex.org/W2323399409","https://openalex.org/W2331980604"],"related_works":["https://openalex.org/W2166893697","https://openalex.org/W237685932","https://openalex.org/W2065327364","https://openalex.org/W2169506749","https://openalex.org/W1984868666","https://openalex.org/W2057530935","https://openalex.org/W4313198630","https://openalex.org/W1971595233","https://openalex.org/W2110713013"],"abstract_inverted_index":{"PGD2,":[0,207],"produced":[1],"by":[2,24,130,168,176,188,206],"mast":[3],"cells,":[4],"has":[5,50,99],"been":[6,51],"detected":[7],"in":[8,46,67,85,107,134,229,237,252],"high":[9],"concentrations":[10,113],"at":[11,115],"sites":[12,116],"of":[13,71,110,117,125,142,164,240,249,255],"allergic":[14,48,118,256],"inflammation.":[15],"It":[16],"can":[17,80],"stimulate":[18,103],"vascular":[19],"and":[20,31,62,78,128,153,190,244],"other":[21,242],"inflammatory":[22],"responses":[23,49],"interaction":[25],"with":[26],"D":[27],"prostanoid":[28,197,212],"receptor":[29,198,213],"(DP)":[30],"chemoattractant":[32],"receptor-like":[33],"molecule":[34],"expressed":[35],"on":[36,54],"Th2":[37,82,89,104,132,202,231],"cells":[38,133,232],"(CRTH2)":[39],"receptors.":[40],"A":[41],"significant":[42],"role":[43],"for":[44],"PGD2":[45,76,79,98,120,165,223],"mediating":[47],"suggested":[52],"based":[53],"the":[55,68,92,100,108,123,140,143,169,177,184,209,238,246,253],"observation":[56],"that":[57,183,222],"enhanced":[58],"eosinophilic":[59],"lung":[60],"inflammation":[61],"cytokine":[63,83,105,145,203,227],"production":[64,84,106,124,204,228],"is":[65,186],"apparent":[66],"allergen-challenged":[69],"airways":[70],"transgenic":[72],"mice":[73],"overexpressing":[74],"human":[75,131,230],"synthase,":[77],"enhance":[81],"vitro":[86],"from":[87],"CD3/CD28-costimulated":[88],"cells.":[90],"In":[91],"present":[93],"study,":[94],"we":[95],"investigated":[96],"whether":[97],"ability":[101],"to":[102],"absence":[109,239],"costimulation.":[111],"At":[112],"found":[114],"inflammation,":[119],"preferentially":[121,224],"elicited":[122],"IL-4,":[126],"IL-5,":[127],"IL-13":[129],"a":[135,194,234],"dose-dependent":[136],"manner":[137],"without":[138,217],"affecting":[139],"level":[141],"anti-inflammatory":[144],"IL-10.":[146],"Gene":[147],"transcription":[148],"peaked":[149,156],"within":[150],"2":[151],"h,":[152],"protein":[154],"release":[155],"approximately":[157],"8":[158],"h":[159],"after":[160],"stimulation.":[161],"The":[162],"effect":[163],"was":[166,216],"mimicked":[167],"selective":[170,178,210],"CRTH2":[171,189,250],"agonist":[172,180],"13,14-dihydro-15-keto-PGD2":[173],"but":[174],"not":[175,191],"DP":[179],"BW245C,":[181],"suggesting":[182],"stimulation":[185],"mediated":[187],"DP.":[192],"Ramatroban,":[193],"dual":[195],"CRTH2/thromboxane-like":[196],"antagonist,":[199],"markedly":[200],"inhibited":[201],"induced":[205],"while":[208],"thromboxane-like":[211],"antagonist":[214],"SQ29548":[215],"effect.":[218],"These":[219],"data":[220],"suggest":[221],"up-regulates":[225],"proinflammatory":[226],"through":[233],"CRTH2-dependent":[235],"mechanism":[236],"any":[241],"costimulation":[243],"highlight":[245],"potential":[247],"utility":[248],"antagonists":[251],"treatment":[254],"diseases.":[257]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2100705331","counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":8},{"year":2022,"cited_by_count":21},{"year":2021,"cited_by_count":18},{"year":2020,"cited_by_count":14},{"year":2019,"cited_by_count":16},{"year":2018,"cited_by_count":22},{"year":2017,"cited_by_count":12},{"year":2016,"cited_by_count":16},{"year":2015,"cited_by_count":19},{"year":2014,"cited_by_count":22},{"year":2013,"cited_by_count":11},{"year":2012,"cited_by_count":22}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
